Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > TOMO > Summary

TomoTherapy Incorporated
(TOMO)

3.89USD   Up0.17 (4.57%)   
At 2:30AM IST
 TomoTherapy Incorporated (NasdaqNM:TOMO) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 3.89USD
Trade Time:2:30AM IST
Change:Up0.17 (4.57%)
Prev Close:3.72
Open:3.83
Bid:3.33 x 2700
Ask:N/A
1y Target Est:4.25
Day's Range:3.74 - 3.93
52wk Range:1.99 - 4.67
Volume:149,024
Avg Vol (3m):169,722
Market Cap:208.91M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A%)
Add TOMO to Portfolio   Download Data

HEADLINES

 
•TomoTherapy Enters Australian Market With Purchase by Royal Brisbane & Women's Hospital - Marketwire  - Tue 7:35PM
•TOMOTHERAPY INC Financials - EDGAR Online Financials  - Sat, Feb 6
•TomoTherapy to Announce Fourth-Quarter Results on Wednesday, February 17, 2010 - Marketwire  - Fri, Feb 5
•Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of TomoTherapy Incorporated Who Invested in the Company's 401(k) Plan - Business Wire  - Wed, Feb 3
•Addenbrooke's Hospital Begins Treating Patients on Second TomoTherapy(R) Cancer Treatment System - Marketwire  - Tue, Feb 2
•Robbins Umeda LLP Announces Investigation of TomoTherapy Incorporated - Business Wire  - Tue, Feb 2
•12 To 24 Month Payback For Hospital Investment In Radiation Oncology Equipment Creates Upside For The Stocks Of These Medical Equipment Suppliers - Wall Street Transcript  - Mon, Jan 25
•TOMOTHERAPY INC Files SEC form 10-K/A, Annual Report - EDGAR Online  - Fri, Jan 15
•TOMOTHERAPY INC Files SEC form 8-K, Change in Directors or Principal Officers - EDGAR Online  - Thu, Jan 14
•TomoTherapy to Present at Needham Growth Stock Conference - Marketwire  - Mon, Jan 11
» More Headlines for TOMO...

ANALYST

 
EPS Est (next year) (Dec-09) :-0.82
EPS Est (in 2 years) (Dec-10) :-0.61
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
TomoTherapy, Incorporated and its subsidiaries develop, manufacture, market, and sell the Hi Art system, a radiation therapy system for the treatment of various types of cancer.

» Full Company Profile